The ATTAIN program encompasses multiple Phase 3 trials in obesity (ATTAIN-1, ATTAIN-2, ATTAIN-3, ATTAIN-MAINTAIN), while the ACHIEVE program covers type 2 diabetes indications (ACHIEVE-1 through ACHIEVE-5, plus regional studies)
The results of this study are consistent with the results of the phase 1 pilot clinical study showing CMCS supplementation was safe and well-tolerated in patients with NAFLD, and highlights the important role of mitochondrial health
Unfortunately, though, things like a poor diet, pollution, toxins, medications, stress, trauma, aging, infections, and radiation all deplete the bodys glutathione levels
Avoid watching TV and using computers, tablets or smartphones in your bedroom
Preclinical and translational studies have examined these peptide classes in models related to endocrine regulation, metabolism, and recovery oriented research questions, with outcomes dependent on study design and assays used